Could a diabetes drug help young adults with rare obesity conditions lose weight?
Disease control
Recruiting now
This study is testing a weight-loss medication called tirzepatide in young adults aged 18-26 who have obesity due to Prader-Willi syndrome, hypothalamic obesity, or general causes. Participants will take the drug for one year to see how much weight they lose and how their health …
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated May 17, 2026 06:47 UTC